Market Cap | ₹70Cr |
ROE | 0.99% |
P/E Ratio(TTM) | 162.79 |
EPS(TTM) | 0.43 |
P/B Ratio | 2.05 |
Dividend Yield | 0.00% |
Industry P/E | 35.04 |
Book Value | 34.11 |
Debt to Equity | 0.50 |
Face Value | 10 |
Parent Organisation | Concord Drugs Limited |
Managing Director | Mr. Seelam Reddy |
BSE Symbol | 538965 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 113.86 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.02 | ||
Emcure Pharmaceuticals | NA (0.00%) | 35.08 | ||
Wockhardt | NA (0.00%) | -201.86 |